Plain-English translation of NCT04932928 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a wearable continuous glucose monitoring device called FreeStyle Libre helps people with type 2 diabetes better control their blood sugar compared to traditional finger-stick blood tests. Everyone in the study will also receive personalized education and coaching on lifestyle changes like diet and exercise. The researchers want to see if real-time glucose readings from the wearable device help patients make better decisions about their daily habits.
Many people with type 2 diabetes struggle to keep their blood sugar in a healthy range. This study looks at whether giving patients immediate feedback about how their food and activity choices affect their glucose levels—through a wearable monitor—might help them succeed better than the traditional approach of testing a few times per day.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either wear a continuous glucose monitor or use traditional finger-stick testing, and both groups will receive education on diet and exercise changes. You'll have check-in phone calls every 4 weeks to review your progress and get support. The study lasts 12 weeks total, with blood tests and questionnaires at the start and end to measure how well your blood sugar control has improved.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea